HRES 681
110th Congress
House
Health
Administrative procedure
Blood diseases
Cancer
Chemotherapy
Department of Health and Human Services
Drugs
Government Operations and Politics
Law
Medicaid
Medicare
Social Welfare
To express the sense of the House of Representatives regarding the Medicare national coverage determination on the treatment of anemia in cancer patients.
Introduced: September 25, 2007
Introduced by:
Cohen, Steve
Democratic
· Tennessee
See on congress.gov
Everywhere this bill has been
4 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Nov 8, 2007
Referred to the Subcommittee on Health.
Oct 3, 2007
Referred to the Subcommittee on Health.
Sep 25, 2007
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 25, 2007
Introduced in House
Plain-English summary
Expresses the sense of the House of Representatives that the Centers for Medicare and Medicaid Services should: (1) begin an immediate reconsideration of the final National Coverage Determination on the Use of Erythropoiesis Stimulating Agents in Cancer and Related Neoplastic Conditions; (2) consult with members of the clinical oncology community to determine appropriate revisions to such Determination; and (3) implement appropriate revisions to such Determination as soon as feasible and provide a briefing to Congress in advance of announcing such changes.
What's happening now
Referred to the Subcommittee on Health.
Committees of jurisdiction
4